103928,1,Admission,O
103928,1,Date,O
103928,1,:,O
103928,1,[,O
103928,1,**2153-9-18**,O
103928,1,],O
103928,1,Discharge,O
103928,1,Date,O
103928,1,:,O
103928,1,[,O
103928,1,**2153-10-4**,O
103928,1,],O
103928,1,Date,O
103928,1,of,O
103928,1,Birth,O
103928,1,:,O
103928,1,[,O
103928,1,**2079-3-29**,O
103928,1,],O
103928,1,Sex,O
103928,1,:,O
103928,1,M,O
103928,1,Service,O
103928,1,:,O
103928,1,MEDICINE,O
103928,1,Allergies,O
103928,1,:,O
103928,1,Percocet,B-Drug
103928,1,/,O
103928,1,Codeine,B-Drug
103928,1,/,O
103928,1,Demerol,B-Drug
103928,1,/,O
103928,1,Nafcillin,B-Drug
103928,1,Attending,O
103928,1,:,O
103928,1,[,O
103928,1,**First,O
103928,1,Name3,O
103928,1,(,O
103928,1,LF,O
103928,1,),O
103928,1,689**,O
103928,1,],O
103928,1,Chief,O
103928,1,Complaint,O
103928,1,:,O
103928,1,Cellulitis,O
103928,1,",",O
103928,1,troponin,O
103928,1,leak,O
103928,1,Major,O
103928,1,Surgical,O
103928,1,or,O
103928,1,Invasive,O
103928,1,Procedure,O
103928,1,:,O
103928,1,Bedside,O
103928,1,debridement,O
103928,1,of,O
103928,1,eschar,O
103928,1,on,O
103928,1,right,O
103928,1,foot,O
103928,1,History,O
103928,1,of,O
103928,1,Present,O
103928,1,Illness,O
103928,1,:,O
103928,1,74,O
103928,1,yo,O
103928,1,M,O
103928,1,with,O
103928,1,MM,O
103928,1,including,O
103928,1,PVD,O
103928,1,",",O
103928,1,DM,O
103928,1,",",O
103928,1,HTN,O
103928,1,",",O
103928,1,CAD,O
103928,1,",",O
103928,1,CRI,O
103928,1,transferred,O
103928,1,from,O
103928,1,NWH,O
103928,1,for,O
103928,1,cellulitis/LE,O
103928,1,pain,O
103928,1,because,O
103928,1,pt,O
103928,1,'s,O
103928,1,podiatric,O
103928,1,surgeon,O
103928,1,is,O
103928,1,at,O
103928,1,[,O
103928,1,**Hospital1,O
103928,1,18**,O
103928,1,],O
103928,1,.,O
103928,1,Initally,O
103928,1,presented,O
103928,1,to,O
103928,1,NWH,O
103928,1,because,O
103928,1,of,O
103928,1,increasing,O
103928,1,right,O
103928,1,foot,O
103928,1,pain,O
103928,1,and,O
103928,1,redness,O
103928,1,.,O
103928,1,At,O
103928,1,NWH,O
103928,1,",",O
103928,1,found,O
103928,1,to,O
103928,1,have,O
103928,1,EKG,O
103928,1,changes,O
103928,1,with,O
103928,1,STD,O
103928,1,in,O
103928,1,V2-V4,O
103928,1,",",O
103928,1,though,O
103928,1,patient,O
103928,1,was,O
103928,1,asymptomatic,O
103928,1,and,O
103928,1,said,O
103928,1,he,O
103928,1,never,O
103928,1,had,O
103928,1,chest,O
103928,1,pain,O
103928,1,.,O
103928,1,Unclear,O
103928,1,if,O
103928,1,he,O
103928,1,received,O
103928,1,abx,O
103928,1,from,O
103928,1,there,O
103928,1,per,O
103928,1,records,O
103928,1,available,O
103928,1,.,O
103928,1,Patient,O
103928,1,was,O
103928,1,transferred,O
103928,1,here,O
103928,1,for,O
103928,1,further,O
103928,1,management,O
103928,1,.,O
103928,1,.,O
103928,1,Of,O
103928,1,note,O
103928,1,",",O
103928,1,patient,O
103928,1,was,O
103928,1,recently,O
103928,1,hospitalized,O
103928,1,[,O
103928,1,**Date,O
103928,1,range,O
103928,1,(,O
103928,1,1,O
103928,1,),O
103928,1,91344**,O
103928,1,],O
103928,1,in,O
103928,1,the,O
103928,1,ICU,O
103928,1,at,O
103928,1,NWH,O
103928,1,when,O
103928,1,he,O
103928,1,was,O
103928,1,found,O
103928,1,at,O
103928,1,home,O
103928,1,unresponsive,O
103928,1,-,O
103928,1,was,O
103928,1,hypoglycemic,O
103928,1,and,O
103928,1,in,O
103928,1,ARF,O
103928,1,.,O
103928,1,Patient,O
103928,1,states,O
103928,1,he,O
103928,1,does,O
103928,1,not,O
103928,1,remember,O
103928,1,'anything,O
103928,1,',O
103928,1,about,O
103928,1,that,O
103928,1,hospital,O
103928,1,stay,O
103928,1,",",O
103928,1,the,O
103928,1,medications,O
103928,1,he,O
103928,1,was,O
103928,1,on,O
103928,1,or,O
103928,1,any,O
103928,1,events,O
103928,1,that,O
103928,1,occurred,O
103928,1,then,O
103928,1,.,O
103928,1,Per,O
103928,1,report,O
103928,1,",",O
103928,1,he,O
103928,1,was,O
103928,1,discharged,O
103928,1,on,O
103928,1,lovenox,B-Drug
103928,1,for,O
103928,1,DVT,B-Reason
103928,1,but,O
103928,1,when,O
103928,1,NWH,O
103928,1,ED,O
103928,1,was,O
103928,1,[,O
103928,1,**Name,O
103928,1,(,O
103928,1,NI,O
103928,1,),O
103928,1,653**,O
103928,1,],O
103928,1,",",O
103928,1,records,O
103928,1,there,O
103928,1,indicated,O
103928,1,that,O
103928,1,he,O
103928,1,was,O
103928,1,started,O
103928,1,on,O
103928,1,Lovenox,B-Drug
103928,1,ppx,O
103928,1,because,O
103928,1,he,O
103928,1,was,O
103928,1,immobile,O
103928,1,and,O
103928,1,was,O
103928,1,supposed,O
103928,1,to,O
103928,1,continue,O
103928,1,taking,O
103928,1,it,O
103928,1,until,O
103928,1,he,O
103928,1,was,O
103928,1,able,O
103928,1,to,O
103928,1,consistently,O
103928,1,walk,O
103928,1,>,O
103928,1,100,O
103928,1,feet,O
103928,1,.,O
103928,1,Unclear,O
103928,1,if,O
103928,1,patient,O
103928,1,has,O
103928,1,been,O
103928,1,administering,O
103928,1,the,O
103928,1,lovenox,B-Drug
103928,1,himself,O
103928,1,as,O
103928,1,he,O
103928,1,stated,O
103928,1,that,O
103928,1,he,O
103928,1,no,O
103928,1,longer,O
103928,1,gives,O
103928,1,himself,O
103928,1,insulin,B-Drug
103928,1,because,O
103928,1,'it,O
103928,1,'s,O
103928,1,just,O
103928,1,too,O
103928,1,complicated,O
103928,1,',O
103928,2,.,O
103928,2,.,O
103928,2,On,O
103928,2,past,O
103928,2,hospitalization,O
103928,2,at,O
103928,2,NWH,O
103928,2,",",O
103928,2,also,O
103928,2,had,O
103928,2,a,O
103928,2,troponin,O
103928,2,has,O
103928,2,high,O
103928,2,as,O
103928,2,8.8,O
103928,2,thought,O
103928,2,be,O
103928,2,due,O
103928,2,to,O
103928,2,demand,B-Reason
103928,2,ischemia,I-Reason
103928,2,in,I-Reason
103928,2,the,I-Reason
103928,2,setting,I-Reason
103928,2,of,I-Reason
103928,2,hypoglycemia,I-Reason
103928,2,.,O
103928,2,During,O
103928,2,that,O
103928,2,admission,O
103928,2,",",O
103928,2,he,O
103928,2,never,O
103928,2,had,O
103928,2,chest,O
103928,2,pain,O
103928,2,and,O
103928,2,a,O
103928,2,stable,O
103928,2,percent,O
103928,2,MB,O
103928,2,fraction,O
103928,2,at,O
103928,2,0.7,O
103928,2,.,O
103928,2,He,O
103928,2,was,O
103928,2,started,O
103928,2,on,O
103928,2,aspirin,B-Drug
103928,2,",",O
103928,2,beta,B-Drug
103928,2,blocker,I-Drug
103928,2,and,O
103928,2,statin,B-Drug
103928,2,.,O
103928,2,An,O
103928,2,ACEi,B-Drug
103928,2,was,O
103928,2,held,O
103928,2,due,O
103928,2,to,O
103928,2,intolerance,B-ADE
103928,2,in,O
103928,2,the,O
103928,2,past,O
103928,2,.,O
103928,2,.,O
103928,2,In,O
103928,2,the,O
103928,2,ED,O
103928,2,here,O
103928,2,VS,O
103928,2,:,O
103928,2,AF,O
103928,2,",",O
103928,2,hr:67,O
103928,2,",",O
103928,2,bp:130/70,O
103928,2,",",O
103928,2,rr:16,O
103928,2,98,O
103928,2,%,O
103928,2,on,O
103928,2,RA,O
103928,2,.,O
103928,2,Received,O
103928,2,fentanyl,B-Drug
103928,2,for,O
103928,2,pain,B-Reason
103928,2,",",O
103928,2,cards,O
103928,2,and,O
103928,2,vascular,O
103928,2,were,O
103928,2,c/s,O
103928,2,.,O
103928,2,Blood,O
103928,2,cx,O
103928,2,were,O
103928,2,drawn,O
103928,2,.,O
103928,2,Vascular,O
103928,2,recommended,O
103928,2,vanc,B-Drug
103928,2,/,O
103928,2,zosyn,B-Drug
103928,2,given,O
103928,2,their,O
103928,2,concern,O
103928,2,for,O
103928,2,osteo,O
103928,2,which,O
103928,2,he,O
103928,2,received,O
103928,2,.,O
103928,2,He,O
103928,2,received,O
103928,2,50mg,O
103928,2,iv,O
103928,2,fentanyl,B-Drug
103928,2,for,O
103928,2,pain,B-Reason
103928,2,.,O
103928,2,.,O
103928,2,Upon,O
103928,2,transfer,O
103928,2,to,O
103928,2,the,O
103928,2,floor,O
103928,2,",",O
103928,2,patient,O
103928,2,c/o,O
103928,2,of,O
103928,2,persistent,O
103928,2,right,O
103928,2,foot,O
103928,2,pain,O
103928,2,.,O
103928,2,Denies,O
103928,2,fever,O
103928,2,or,O
103928,2,chills,O
103928,2,",",O
103928,2,CP,O
103928,2,",",O
103928,2,SOB,O
103928,2,",",O
103928,2,N/V/D,O
103928,2,",",O
103928,2,constipation,O
103928,2,",",O
103928,2,HA,O
103928,2,or,O
103928,2,vision,O
103928,2,changes,O
103928,2,.,O
103928,2,.,O
103928,2,The,O
103928,2,patient,O
103928,2,is,O
103928,2,not,O
103928,2,a,O
103928,2,competent,O
103928,2,historian,O
103928,2,.,O
103928,2,On,O
103928,2,review,O
103928,2,of,O
103928,2,systems,O
103928,2,",",O
103928,2,he,O
103928,2,denies,O
103928,2,any,O
103928,2,prior,O
103928,2,history,O
103928,2,of,O
103928,2,stroke,O
103928,2,",",O
103928,2,TIA,O
103928,2,",",O
103928,2,deep,O
103928,2,venous,O
103928,2,thrombosis,O
103928,2,",",O
103928,2,pulmonary,O
103928,2,embolism,O
103928,2,",",O
103928,2,bleeding,O
103928,2,at,O
103928,2,the,O
103928,2,time,O
103928,2,of,O
103928,2,surgery,O
103928,2,",",O
103928,2,myalgias,O
103928,2,",",O
103928,2,joint,O
103928,2,pains,O
103928,2,",",O
103928,2,cough,O
103928,2,",",O
103928,2,hemoptysis,O
103928,2,",",O
103928,2,black,O
103928,2,stools,O
103928,2,or,O
103928,2,red,O
103928,2,stools,O
103928,2,.,O
103928,2,He,O
103928,2,denies,O
103928,2,recent,O
103928,2,fevers,O
103928,2,",",O
103928,2,chills,O
103928,2,or,O
103928,2,rigors,O
103928,2,.,O
103928,2,He,O
103928,2,denies,O
103928,2,exertional,O
103928,2,buttock,O
103928,2,or,O
103928,2,calf,O
103928,2,pain,O
103928,2,.,O
103928,2,All,O
103928,2,of,O
103928,2,the,O
103928,2,other,O
103928,2,review,O
103928,2,of,O
103928,2,systems,O
103928,2,per,O
103928,2,HPI,O
103928,2,.,O
103928,2,.,O
103928,2,Cardiac,O
103928,2,review,O
103928,2,of,O
103928,2,systems,O
103928,2,is,O
103928,2,notable,O
103928,2,for,O
103928,2,absence,O
103928,2,of,O
103928,2,chest,O
103928,2,pain,O
103928,2,",",O
103928,2,dyspnea,O
103928,2,on,O
103928,2,exertion,O
103928,2,",",O
103928,2,paroxysmal,O
103928,2,nocturnal,O
103928,2,dyspnea,O
103928,2,",",O
103928,2,orthopnea,O
103928,2,",",O
103928,2,ankle,O
103928,2,edema,O
103928,2,",",O
103928,2,palpitations,O
103928,2,",",O
103928,2,syncope,O
103928,2,or,O
103928,2,presyncope,O
103928,2,.,O
103928,2,Past,O
103928,2,Medical,O
103928,2,History,O
103928,2,:,O
103928,2,1,O
103928,2,.,O
103928,2,CARDIAC,O
103928,2,RISK,O
103928,2,FACTORS,O
103928,2,:,O
103928,2,(,O
103928,2,+,O
103928,2,),O
103928,2,Diabetes,O
103928,2,",",O
103928,2,(,O
103928,2,+,O
103928,2,),O
103928,2,Dyslipidemia,O
103928,2,",",O
103928,2,(,O
103928,2,+,O
103928,2,),O
103928,2,HTN,O
103928,2,2,O
103928,2,.,O
103928,2,CARDIAC,O
103928,2,HISTORY,O
103928,2,:,O
103928,2,-CABG,O
103928,3,:,O
103928,3,[,O
103928,3,**2137**,O
103928,3,],O
103928,3,LIMA-,O
103928,3,>,O
103928,3,LAD,O
103928,3,.,O
103928,3,SVG-,O
103928,3,>,O
103928,3,dRCA,O
103928,3,and,O
103928,3,SVG-,O
103928,3,>,O
103928,3,D1/OM,O
103928,3,.,O
103928,3,-PERCUTANEOUS,O
103928,3,CORONARY,O
103928,3,INTERVENTIONS,O
103928,3,:,O
103928,3,[,O
103928,3,**2150**,O
103928,3,],O
103928,3,(,O
103928,3,no,O
103928,3,report,O
103928,3,available,O
103928,3,),O
103928,3,",",O
103928,3,[,O
103928,3,**2147**,O
103928,3,],O
103928,3,:,O
103928,3,3VD,O
103928,3,",",O
103928,3,patent,O
103928,3,LIMA,O
103928,3,--,O
103928,3,>,O
103928,3,LAD,O
103928,3,",",O
103928,3,patnet,O
103928,3,SVG,O
103928,3,--,O
103928,3,>,O
103928,3,dRCA,O
103928,3,and,O
103928,3,D1/OM,O
103928,3,",",O
103928,3,severe,O
103928,3,native,O
103928,3,vessel,O
103928,3,disease,O
103928,3,.,O
103928,3,-PACING/ICD,O
103928,3,:,O
103928,3,None,O
103928,3,.,O
103928,3,3,O
103928,3,.,O
103928,3,OTHER,O
103928,3,PAST,O
103928,3,MEDICAL,O
103928,3,HISTORY,O
103928,3,:,O
103928,3,Per,O
103928,3,OMR,O
103928,3,notes,O
103928,3,",",O
103928,3,patient,O
103928,3,states,O
103928,3,he,O
103928,3,does,O
103928,3,not,O
103928,3,know,O
103928,3,his,O
103928,3,full,O
103928,3,medical,O
103928,3,history,O
103928,3,PVD,O
103928,3,CAD,O
103928,3,s/p,O
103928,3,MI,O
103928,3,in,O
103928,3,',O
103928,3,[,O
103928,3,**49**,O
103928,3,],O
103928,3,HTN,O
103928,3,Hyperlipidemia,O
103928,3,DM2,B-Reason
103928,3,on,O
103928,3,Insulin,B-Drug
103928,3,Diastolic,O
103928,3,CHF,O
103928,3,CRI,O
103928,3,(,O
103928,3,baseline,O
103928,3,1.8-2,O
103928,3,),O
103928,3,h/o,O
103928,3,GI,O
103928,3,bleed,O
103928,3,Bladder,O
103928,3,carcinoma,O
103928,3,Cervical,O
103928,3,stenosis,O
103928,3,Anemia,O
103928,3,Gastroparesis,O
103928,3,.,O
103928,3,PAST,O
103928,3,SURGICAL,O
103928,3,HISTORY,O
103928,3,:,O
103928,3,-,O
103928,3,Debridement,O
103928,3,of,O
103928,3,osteomyelitis,O
103928,3,with,O
103928,3,L.,O
103928,3,5th,O
103928,3,metatarsal,O
103928,3,head,O
103928,3,resection,O
103928,3,[,O
103928,3,**2153-4-19**,O
103928,3,],O
103928,3,-,O
103928,3,L,O
103928,3,CFA,O
103928,3,to,O
103928,3,BK,O
103928,3,[,O
103928,3,**Doctor,O
103928,3,Last,O
103928,3,Name,O
103928,3,**,O
103928,3,],O
103928,3,bypass,O
103928,3,with,O
103928,3,left,O
103928,3,arm,O
103928,3,vein,O
103928,3,[,O
103928,3,**9-27**,O
103928,3,],O
103928,3,-,O
103928,3,L4-5,O
103928,3,laminectomies,O
103928,3,bilat,O
103928,3,w/,O
103928,3,resection,O
103928,3,of,O
103928,3,large,O
103928,3,disk,O
103928,3,herniation,O
103928,3,[,O
103928,3,**4-24**,O
103928,3,],O
103928,3,-,O
103928,3,R,O
103928,3,2nd,O
103928,3,second,O
103928,3,toe,O
103928,3,amp,O
103928,3,[,O
103928,3,**5-24**,O
103928,3,],O
103928,3,-,O
103928,3,R,O
103928,3,CFA,O
103928,3,to,O
103928,3,AK,O
103928,3,[,O
103928,3,**Doctor,O
103928,3,Last,O
103928,3,Name,O
103928,3,**,O
103928,3,],O
103928,3,bypass,O
103928,3,using,O
103928,3,[,O
103928,3,**Doctor,O
103928,3,Last,O
103928,3,Name,O
103928,3,4726**,O
103928,3,],O
103928,3,-Tex,O
103928,3,[,O
103928,3,**4-23**,O
103928,3,],O
103928,3,-,O
103928,3,L,O
103928,3,CEA,O
103928,3,[,O
103928,3,**2-/2140**,O
103928,3,],O
103928,3,",",O
103928,3,4,O
103928,3,vessel,O
103928,3,CABG,O
103928,3,[,O
103928,3,**1-/2138**,O
103928,3,],O
103928,3,-,O
103928,3,Aorta-bifemoral,O
103928,3,bypass,O
103928,3,at,O
103928,3,NWH,O
103928,3,in,O
103928,3,[,O
103928,3,**2147**,O
103928,3,],O
103928,3,?,O
103928,3,Social,O
103928,3,History,O
103928,3,:,O
103928,3,HISTORY,O
103928,3,:,O
103928,3,Unwilling,O
103928,3,to,O
103928,3,give,O
103928,3,.,O
103928,3,Per,O
103928,3,prior,O
103928,3,records,O
103928,3,",",O
103928,3,married,O
103928,3,twice,O
103928,3,",",O
103928,3,but,O
103928,3,recently,O
103928,3,separated,O
103928,3,.,O
103928,3,He,O
103928,3,has,O
103928,3,two,O
103928,3,children,O
103928,3,.,O
103928,3,H/o,O
103928,3,EtOH,O
103928,3,abuse,O
103928,3,in,O
103928,3,AA,O
103928,3,35,O
103928,3,yrs,O
103928,3,;,O
103928,3,tobacco,O
103928,3,45,O
103928,3,pack,O
103928,3,year,O
103928,3,history,O
103928,3,Family,O
103928,3,History,O
103928,3,:,O
103928,3,Non-contributory,O
103928,3,Physical,O
103928,3,Exam,O
103928,3,:,O
103928,3,ADMISSION,O
103928,3,PHYSICAL,O
103928,3,EXAMINATION,O
103928,3,:,O
103928,3,VS,O
103928,3,:,O
103928,3,T=97.9,O
103928,3,BP=140/60,O
103928,3,HR=72,O
103928,3,RR=20,O
103928,3,O2,B-Drug
103928,3,sat=93,O
103928,3,on,O
103928,3,2L,O
103928,3,%,O
103928,3,GENERAL,O
103928,3,:,O
103928,3,elderly,O
103928,3,male,O
103928,3,lying,O
103928,3,in,O
103928,3,bed,O
103928,3,.,O
103928,3,Oriented,O
103928,3,x3,O
103928,3,.,O
103928,3,Mood,O
103928,3,appropriate,O
103928,3,.,O
103928,3,HEENT,O
103928,3,:,O
103928,3,NCAT,O
103928,3,.,O
103928,3,Sclera,O
103928,3,anicteric,O
103928,3,.,O
103928,3,PERRL,O
103928,3,",",O
103928,3,EOMI,O
103928,3,.,O
103928,3,dry,O
103928,4,mmm,O
103928,4,.,O
103928,4,Poor,O
103928,4,dentition,O
103928,4,NECK,O
103928,4,:,O
103928,4,Supple,O
103928,4,.,O
103928,4,No,O
103928,4,JVD,O
103928,4,.,O
103928,4,CARDIAC,O
103928,4,:,O
103928,4,RRR,O
103928,4,.,O
103928,4,s1/s2,O
103928,4,.,O
103928,4,III/VI,O
103928,4,systolic,O
103928,4,murmur,O
103928,4,heard,O
103928,4,best,O
103928,4,at,O
103928,4,LLSB,O
103928,4,.,O
103928,4,LUNGS,O
103928,4,:,O
103928,4,clear,O
103928,4,anteriorly,O
103928,4,.,O
103928,4,patient,O
103928,4,unwilling,O
103928,4,to,O
103928,4,fully,O
103928,4,sit,O
103928,4,up,O
103928,4,for,O
103928,4,posterior,O
103928,4,thorax,O
103928,4,exam,O
103928,4,",",O
103928,4,so,O
103928,4,limited,O
103928,4,.,O
103928,4,Heard,O
103928,4,scattered,O
103928,4,wheezes,O
103928,4,and,O
103928,4,crackles,O
103928,4,at,O
103928,4,bases,O
103928,4,posteriorly,O
103928,4,.,O
103928,4,ABDOMEN,O
103928,4,:,O
103928,4,Soft,O
103928,4,",",O
103928,4,NTND,O
103928,4,.,O
103928,4,+bs,O
103928,4,EXTREMITIES,O
103928,4,:,O
103928,4,chronic,O
103928,4,venous,O
103928,4,statis,O
103928,4,changes,O
103928,4,bilaterlly,O
103928,4,.,O
103928,4,warm,O
103928,4,to,O
103928,4,touch,O
103928,4,",",O
103928,4,DP,O
103928,4,pulses,O
103928,4,dopplerable,O
103928,4,.,O
103928,4,RLE,O
103928,4,:,O
103928,4,2,O
103928,4,eshcars,O
103928,4,-,O
103928,4,one,O
103928,4,on,O
103928,4,medial,O
103928,4,aspect,O
103928,4,of,O
103928,4,foot,O
103928,4,and,O
103928,4,one,O
103928,4,on,O
103928,4,plantar,O
103928,4,aspect,O
103928,4,of,O
103928,4,foot,O
103928,4,.,O
103928,4,Area,O
103928,4,of,O
103928,4,erythema,O
103928,4,on,O
103928,4,anterior/medial,O
103928,4,aspect,O
103928,4,of,O
103928,4,foot,O
103928,4,with,O
103928,4,increased,O
103928,4,warmth,O
103928,4,.,O
103928,4,?,O
103928,4,collection,O
103928,4,under,O
103928,4,foot,O
103928,4,?,O
103928,4,SKIN,O
103928,4,:,O
103928,4,as,O
103928,4,above,O
103928,4,Pertinent,O
103928,4,Results,O
103928,4,:,O
103928,4,Admission,O
103928,4,laboratories,O
103928,4,:,O
103928,4,COMPLETE,O
103928,4,BLOOD,O
103928,4,COUNT,O
103928,4,(,O
103928,4,[,O
103928,4,**9-18**,O
103928,4,],O
103928,4,),O
103928,4,WBC,O
103928,4,:,O
103928,4,9.2,O
103928,4,RBC,O
103928,4,:,O
103928,4,3.45*,O
103928,4,Hgb,O
103928,4,:,O
103928,4,8.3*,O
103928,4,#,O
103928,4,Hct:27.6*,O
103928,4,MCV:80*,O
103928,4,MCH:23.9*,O
103928,4,MCHC:30.0*,O
103928,4,RDW:24.4*,O
103928,4,Plt,O
103928,4,Ct,O
103928,4,:,O
103928,4,300,O
103928,4,DIFFERENTIAL,O
103928,4,Neuts,O
103928,4,87.1*,O
103928,4,Bands,O
103928,4,Lymphs,O
103928,4,6.3*,O
103928,4,Monos,O
103928,4,4.8,O
103928,4,Eos,O
103928,4,1.4,O
103928,4,Baso,O
103928,4,0.5,O
103928,4,[,O
103928,4,**2153-9-18**,O
103928,4,],O
103928,4,07:01PM,O
103928,4,BASIC,O
103928,4,COAGULATION,O
103928,4,(,O
103928,4,PT,O
103928,4,",",O
103928,4,PTT,O
103928,4,",",O
103928,4,PLT,O
103928,4,",",O
103928,4,INR,O
103928,4,),O
103928,4,PT,O
103928,4,15.0*PTT,O
103928,4,41.8*Plt,O
103928,4,Ct,O
103928,4,INR,O
103928,4,(,O
103928,4,PT,O
103928,4,),O
103928,4,1.3*,O
103928,4,Chemistry,O
103928,4,RENAL,O
103928,4,&,O
103928,4,GLUCOSE,O
103928,4,Glucose,O
103928,4,278*,O
103928,4,UreaN,O
103928,4,69*,O
103928,4,Creat,O
103928,4,2.0*,O
103928,4,Na,O
103928,4,132*,O
103928,4,K,O
103928,4,4.6,O
103928,4,Cl,O
103928,4,98,O
103928,4,HCO3,O
103928,4,22,O
103928,4,EKG,O
103928,4,(,O
103928,4,[,O
103928,4,**9-20**,O
103928,4,],O
103928,4,),O
103928,4,:,O
103928,4,Sinus,O
103928,4,rhythm,O
103928,4,.,O
103928,4,Right,O
103928,4,axis,O
103928,4,deviation,O
103928,4,.,O
103928,4,Incomplete,O
103928,4,right,O
103928,4,bundle,O
103928,4,branch,O
103928,4,block,O
103928,4,.,O
103928,4,One,O
103928,4,to,O
103928,4,two,O
103928,4,millimeter,O
103928,4,downsloping,O
103928,4,ST,O
103928,4,segment,O
103928,4,depression,O
103928,4,in,O
103928,4,the,O
103928,4,anterior,O
103928,4,leads,O
103928,4,extending,O
103928,4,from,O
103928,4,leads,O
103928,4,V3-V6,O
103928,4,.,O
103928,4,Consider,O
103928,4,myocardial,O
103928,4,ischemia,O
103928,4,.,O
103928,4,Compared,O
103928,4,to,O
103928,4,the,O
103928,4,previous,O
103928,4,tracing,O
103928,4,of,O
103928,4,[,O
103928,4,**2153-9-19**,O
103928,4,],O
103928,4,the,O
103928,4,ST-T,O
103928,4,wave,O
103928,4,changes,O
103928,4,are,O
103928,4,pretty,O
103928,4,similar,O
103928,4,except,O
103928,4,that,O
103928,4,the,O
103928,4,lead,O
103928,4,placement,O
103928,4,is,O
103928,4,slightly,O
103928,4,different,O
103928,4,.,O
103928,4,Rate,O
103928,4,PR,O
103928,4,QRS,O
103928,4,QT/QTc,O
103928,4,P,O
103928,4,QRS,O
103928,4,T,O
103928,4,72,O
103928,4,126,O
103928,4,114,O
103928,4,440/461,O
103928,4,71,O
103928,4,121,O
103928,4,113,O
103928,4,WOUND,O
103928,4,CULTURE,O
103928,4,(,O
103928,4,Final,O
103928,4,[,O
103928,4,**2153-9-25**,O
103928,4,],O
103928,4,),O
103928,4,:,O
103928,4,KLEBSIELLA,O
103928,4,OXYTOCA,O
103928,4,.,O
103928,4,SPARSE,O
103928,4,GROWTH,O
103928,4,.,O
103928,4,STAPH,O
103928,4,AUREUS,O
103928,5,COAG,O
103928,5,+,O
103928,5,.,O
103928,5,SPARSE,O
103928,5,GROWTH,O
103928,5,.,O
103928,5,Oxacillin,B-Drug
103928,5,RESISTANT,O
103928,5,Staphylococci,O
103928,5,MUST,O
103928,5,be,O
103928,5,reported,O
103928,5,as,O
103928,5,also,O
103928,5,RESISTANT,O
103928,5,to,O
103928,5,other,O
103928,5,penicillins,B-Drug
103928,5,",",O
103928,5,cephalosporins,O
103928,5,",",O
103928,5,carbacephems,B-Drug
103928,5,",",O
103928,5,carbapenems,B-Drug
103928,5,",",O
103928,5,and,O
103928,5,beta-lactamase,B-Drug
103928,5,inhibitor,I-Drug
103928,5,combinations,I-Drug
103928,5,.,O
103928,5,Rifampin,B-Drug
103928,5,should,O
103928,5,not,O
103928,5,be,O
103928,5,used,O
103928,5,alone,O
103928,5,for,O
103928,5,therapy,O
103928,5,.,O
103928,5,Please,O
103928,5,contact,O
103928,5,the,O
103928,5,Microbiology,O
103928,5,Laboratory,O
103928,5,(,O
103928,5,[,O
103928,5,**6-/2450**,O
103928,5,],O
103928,5,),O
103928,5,immediately,O
103928,5,if,O
103928,5,sensitivity,O
103928,5,to,O
103928,5,clindamycin,B-Drug
103928,5,is,O
103928,5,required,O
103928,5,on,O
103928,5,this,O
103928,5,patient,O
103928,5,'s,O
103928,5,isolate,O
103928,5,.,O
103928,5,SENSITIVITIES,O
103928,5,:,O
103928,5,MIC,O
103928,5,expressed,O
103928,5,in,O
103928,5,MCG/ML,O
103928,5,_________________________________________________________,O
103928,5,KLEBSIELLA,O
103928,5,OXYTOCA,O
103928,5,|,O
103928,5,STAPH,O
103928,5,AUREUS,O
103928,5,COAG,O
103928,5,+,O
103928,5,|,O
103928,5,|,O
103928,5,AMPICILLIN,B-Drug
103928,5,/,O
103928,5,SULBACTAM,B-Drug
103928,5,--,O
103928,5,8,O
103928,5,S,O
103928,5,CEFAZOLIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,8,O
103928,5,S,O
103928,5,CEFEPIME,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,CEFTAZIDIME,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,CEFTRIAXONE,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,CEFUROXIME,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,4,O
103928,5,S,O
103928,5,CIPROFLOXACIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,<,O
103928,5,=0.25,O
103928,5,S,O
103928,5,ERYTHROMYCIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,=,O
103928,5,>,O
103928,5,8,O
103928,5,R,O
103928,5,GENTAMICIN,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,<,O
103928,5,=0.5,O
103928,5,S,O
103928,5,LEVOFLOXACIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,=,O
103928,5,>,O
103928,5,8,O
103928,5,R,O
103928,5,MEROPENEM,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,<,O
103928,5,=0.25,O
103928,5,S,O
103928,5,OXACILLIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,=,O
103928,5,>,O
103928,5,4,O
103928,5,R,O
103928,5,PIPERACILLIN,B-Drug
103928,5,/TAZO,O
103928,5,--,O
103928,5,--,O
103928,5,-,O
103928,5,<,O
103928,5,=4,O
103928,5,S,O
103928,5,RIFAMPIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=0.5,O
103928,5,S,O
103928,5,TETRACYCLINE,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,TOBRAMYCIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,TRIMETHOPRIM,B-Drug
103928,5,/SULFA,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,<,O
103928,5,=0.5,O
103928,5,S,O
103928,5,VANCOMYCIN,B-Drug
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,--,O
103928,5,<,O
103928,5,=1,O
103928,5,S,O
103928,5,ANAEROBIC,O
103928,5,CULTURE,O
103928,5,(,O
103928,5,Final,O
103928,5,[,O
103928,5,**2153-9-24**,O
103928,5,],O
103928,5,),O
103928,5,:,O
103928,5,NO,O
103928,5,ANAEROBES,O
103928,5,ISOLATED,O
103928,5,.,O
103928,5,Imaging,O
103928,5,:,O
103928,5,Xray,O
103928,5,of,O
103928,5,right,O
103928,5,foot,O
103928,5,(,O
103928,5,[,O
103928,5,**9-19**,O
103928,5,],O
103928,5,),O
103928,5,:,O
103928,5,IMPRESSION,O
103928,5,:,O
103928,5,1,O
103928,5,.,O
103928,5,Erosive,O
103928,5,bony,O
103928,5,destructions,O
103928,5,at,O
103928,5,the,O
103928,5,first,O
103928,5,distal,O
103928,5,phalanx,O
103928,5,and,O
103928,5,at,O
103928,5,the,O
103928,5,stump,O
103928,5,of,O
103928,5,the,O
103928,6,second,O
103928,6,proximal,O
103928,6,phalanx,O
103928,6,consistent,O
103928,6,with,O
103928,6,osteomyelitis,O
103928,6,.,O
103928,6,2,O
103928,6,.,O
103928,6,Severe,O
103928,6,degenerative,O
103928,6,changes,O
103928,6,in,O
103928,6,the,O
103928,6,tarsometatarsal,O
103928,6,joints,O
103928,6,and,O
103928,6,fracture,O
103928,6,at,O
103928,6,the,O
103928,6,3rd,O
103928,6,metatarsal,O
103928,6,",",O
103928,6,suggesting,O
103928,6,early,O
103928,6,Charcot,O
103928,6,joint,O
103928,6,disease,O
103928,6,.,O
103928,6,3,O
103928,6,.,O
103928,6,Significant,O
103928,6,small,O
103928,6,vessel,O
103928,6,disease,O
103928,6,.,O
103928,6,2D-ECHOCARDIOGRAM,O
103928,6,(,O
103928,6,[,O
103928,6,**9-20**,O
103928,6,],O
103928,6,),O
103928,6,:,O
103928,6,The,O
103928,6,left,O
103928,6,atrium,O
103928,6,is,O
103928,6,mildly,O
103928,6,dilated,O
103928,6,.,O
103928,6,The,O
103928,6,right,O
103928,6,atrium,O
103928,6,is,O
103928,6,markedly,O
103928,6,dilated,O
103928,6,.,O
103928,6,Left,O
103928,6,ventricular,O
103928,6,wall,O
103928,6,thickness,O
103928,6,",",O
103928,6,cavity,O
103928,6,size,O
103928,6,and,O
103928,6,regional/global,O
103928,6,systolic,O
103928,6,function,O
103928,6,are,O
103928,6,normal,O
103928,6,(,O
103928,6,LVEF,O
103928,6,>,O
103928,6,55,O
103928,6,%,O
103928,6,),O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,no,O
103928,6,left,O
103928,6,ventricular,O
103928,6,outflow,O
103928,6,obstruction,O
103928,6,at,O
103928,6,rest,O
103928,6,or,O
103928,6,with,O
103928,6,Valsalva,O
103928,6,.,O
103928,6,The,O
103928,6,right,O
103928,6,ventricular,O
103928,6,cavity,O
103928,6,is,O
103928,6,markedly,O
103928,6,dilated,O
103928,6,with,O
103928,6,moderate,O
103928,6,global,O
103928,6,free,O
103928,6,wall,O
103928,6,hypokinesis,O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,abnormal,O
103928,6,septal,O
103928,6,motion/position,O
103928,6,consistent,O
103928,6,with,O
103928,6,right,O
103928,6,ventricular,O
103928,6,pressure/volume,O
103928,6,overload,O
103928,6,.,O
103928,6,The,O
103928,6,ascending,O
103928,6,aorta,O
103928,6,is,O
103928,6,moderately,O
103928,6,dilated,O
103928,6,.,O
103928,6,The,O
103928,6,aortic,O
103928,6,valve,O
103928,6,leaflets,O
103928,6,(,O
103928,6,3,O
103928,6,),O
103928,6,are,O
103928,6,mildly,O
103928,6,thickened,O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,mild,O
103928,6,aortic,O
103928,6,valve,O
103928,6,stenosis,O
103928,6,(,O
103928,6,valve,O
103928,6,area,O
103928,6,1.2-1.9cm2,O
103928,6,),O
103928,6,.,O
103928,6,Trace,O
103928,6,aortic,O
103928,6,regurgitation,O
103928,6,is,O
103928,6,seen,O
103928,6,.,O
103928,6,The,O
103928,6,mitral,O
103928,6,valve,O
103928,6,leaflets,O
103928,6,are,O
103928,6,mildly,O
103928,6,thickened,O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,no,O
103928,6,mitral,O
103928,6,valve,O
103928,6,prolapse,O
103928,6,.,O
103928,6,Mild,O
103928,6,to,O
103928,6,moderate,O
103928,6,(,O
103928,6,[,O
103928,6,**12-22**,O
103928,6,],O
103928,6,+,O
103928,6,),O
103928,6,mitral,O
103928,6,regurgitation,O
103928,6,is,O
103928,6,seen,O
103928,6,.,O
103928,6,The,O
103928,6,tricuspid,O
103928,6,valve,O
103928,6,leaflets,O
103928,6,are,O
103928,6,mildly,O
103928,6,thickened,O
103928,6,.,O
103928,6,Moderate,O
103928,6,to,O
103928,6,severe,O
103928,6,[,O
103928,6,3+,O
103928,6,],O
103928,6,tricuspid,O
103928,6,regurgitation,O
103928,6,is,O
103928,6,seen,O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,severe,O
103928,6,pulmonary,O
103928,6,artery,O
103928,6,systolic,O
103928,6,hypertension,O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,no,O
103928,6,pericardial,O
103928,6,effusion,O
103928,6,.,O
103928,6,Compared,O
103928,6,with,O
103928,6,the,O
103928,6,prior,O
103928,6,study,O
103928,6,(,O
103928,6,images,O
103928,6,reviewed,O
103928,6,),O
103928,6,of,O
103928,6,[,O
103928,6,**2151-12-16**,O
103928,6,],O
103928,6,",",O
103928,6,the,O
103928,6,detected,O
103928,6,pulmonary,O
103928,6,hypertension,O
103928,6,has,O
103928,6,increased,O
103928,6,.,O
103928,6,There,O
103928,6,is,O
103928,6,no,O
103928,6,change,O
103928,6,in,O
103928,6,the,O
103928,6,left,O
103928,6,ventricular,O
103928,6,systolic,O
103928,6,function,O
103928,6,.,O
103928,6,ETT,O
103928,6,:,O
103928,6,[,O
103928,6,**4-/2151**,O
103928,6,],O
103928,6,:,O
103928,6,This,O
103928,6,72,O
103928,6,yo,O
103928,6,man,O
103928,6,with,O
103928,6,IDDM,O
103928,6,",",O
103928,6,mild,O
103928,6,AS,O
103928,6,s/p,O
103928,6,multiple,O
103928,6,cadiac,O
103928,6,interventions,O
103928,6,was,O
103928,6,referred,O
103928,6,to,O
103928,6,the,O
103928,6,lab,O
103928,6,for,O
103928,6,evaluation,O
103928,6,as,O
103928,6,a,O
103928,6,part,O
103928,6,of,O
103928,6,the,O
103928,6,Spinal,O
103928,6,Cord,O
103928,6,Stimulation,O
103928,6,study,O
103928,6,.,O
103928,6,The,O
103928,6,patient,O
103928,6,exercised,O
103928,6,for,O
103928,6,2.5,O
103928,6,minutes,O
103928,6,on,O
103928,6,a,O
103928,6,modified,O
103928,6,[,O
103928,6,**Doctor,O
103928,6,First,O
103928,6,Name,O
103928,6,**,O
103928,6,],O
103928,6,protocol,O
103928,6,and,O
103928,6,stopped,O
103928,7,due,O
103928,7,a,O
103928,7,marked,O
103928,7,drop,O
103928,7,in,O
103928,7,systolic,O
103928,7,blood,O
103928,7,pressure,O
103928,7,.,O
103928,7,This,O
103928,7,represents,O
103928,7,a,O
103928,7,very,O
103928,7,limited,O
103928,7,exercise,O
103928,7,tolerance,O
103928,7,for,O
103928,7,his,O
103928,7,age,O
103928,7,.,O
103928,7,The,O
103928,7,patient,O
103928,7,denied,O
103928,7,any,O
103928,7,neck,O
103928,7,",",O
103928,7,chest,O
103928,7,",",O
103928,7,arm,O
103928,7,or,O
103928,7,back,O
103928,7,discomfort,O
103928,7,throughout,O
103928,7,the,O
103928,7,study,O
103928,7,.,O
103928,7,In,O
103928,7,the,O
103928,7,setting,O
103928,7,of,O
103928,7,baseline,O
103928,7,abnormalities,O
103928,7,",",O
103928,7,an,O
103928,7,additional,O
103928,7,0.5mm,O
103928,7,of,O
103928,7,ST,O
103928,7,segment,O
103928,7,depression,O
103928,7,was,O
103928,7,noted,O
103928,7,in,O
103928,7,V4-V5,O
103928,7,at,O
103928,7,peak,O
103928,7,exercise,O
103928,7,.,O
103928,7,These,O
103928,7,changes,O
103928,7,returned,O
103928,7,to,O
103928,7,baseline,O
103928,7,by,O
103928,7,minute,O
103928,7,3,O
103928,7,post-exercise,O
103928,7,.,O
103928,7,The,O
103928,7,rhythm,O
103928,7,was,O
103928,7,sinus,O
103928,7,with,O
103928,7,a,O
103928,7,single,O
103928,7,VPB,O
103928,7,in,O
103928,7,late,O
103928,7,recovery,O
103928,7,period,O
103928,7,.,O
103928,7,Marked,O
103928,7,drop,O
103928,7,in,O
103928,7,blood,O
103928,7,pressure,O
103928,7,with,O
103928,7,exercise,O
103928,7,(,O
103928,7,136/60mmHg,O
103928,7,at,O
103928,7,rest,O
103928,7,to,O
103928,7,98/50mmHg,O
103928,7,at,O
103928,7,peak,O
103928,7,),O
103928,7,.,O
103928,7,Post-exercise,O
103928,7,hypertension,O
103928,7,was,O
103928,7,noted,O
103928,7,(,O
103928,7,172/60mmHg,O
103928,7,at,O
103928,7,10,O
103928,7,minutes,O
103928,7,of,O
103928,7,recovery,O
103928,7,),O
103928,7,.,O
103928,7,.,O
103928,7,IMPRESSION,O
103928,7,:,O
103928,7,Marked,O
103928,7,drop,O
103928,7,in,O
103928,7,blood,O
103928,7,pressure,O
103928,7,with,O
103928,7,exercise,O
103928,7,.,O
103928,7,Non-specific,O
103928,7,EKG,O
103928,7,changes,O
103928,7,without,O
103928,7,anginal,O
103928,7,type,O
103928,7,symptoms,O
103928,7,.,O
103928,7,.,O
103928,7,CARDIAC,O
103928,7,CATH,O
103928,7,:,O
103928,7,[,O
103928,7,**2147**,O
103928,7,],O
103928,7,:,O
103928,7,COMMENTS,O
103928,7,:,O
103928,7,1,O
103928,7,.,O
103928,7,Coronary,O
103928,7,angiography,O
103928,7,of,O
103928,7,this,O
103928,7,right,O
103928,7,dominant,O
103928,7,circulation,O
103928,7,revealed,O
103928,7,severe,O
103928,7,native,O
103928,7,three,O
103928,7,vessel,O
103928,7,disease,O
103928,7,.,O
103928,7,The,O
103928,7,LMCA,O
103928,7,had,O
103928,7,a,O
103928,7,30,O
103928,7,%,O
103928,7,narrowing,O
103928,7,.,O
103928,7,The,O
103928,7,LAD,O
103928,7,had,O
103928,7,diffuse,O
103928,7,luminal,O
103928,7,irregularities,O
103928,7,and,O
103928,7,a,O
103928,7,70,O
103928,7,%,O
103928,7,proximal,O
103928,7,stenosis,O
103928,7,.,O
103928,7,The,O
103928,7,mid,O
103928,7,vessel,O
103928,7,was,O
103928,7,diffusely,O
103928,7,diseased,O
103928,7,but,O
103928,7,the,O
103928,7,distal,O
103928,7,vessel,O
103928,7,filled,O
103928,7,via,O
103928,7,a,O
103928,7,patent,O
103928,7,LIMA-,O
103928,7,>,O
103928,7,dLAD,O
103928,7,.,O
103928,7,The,O
103928,7,LAD,O
103928,7,supplied,O
103928,7,a,O
103928,7,large,O
103928,7,S2,O
103928,7,that,O
103928,7,had,O
103928,7,an,O
103928,7,80,O
103928,7,%,O
103928,7,lesion,O
103928,7,at,O
103928,7,its,O
103928,7,ostium,O
103928,7,.,O
103928,7,The,O
103928,7,LAD,O
103928,7,supplied,O
103928,7,two,O
103928,7,moderate,O
103928,7,sized,O
103928,7,diagonal,O
103928,7,branches,O
103928,7,which,O
103928,7,had,O
103928,7,diffuse,O
103928,7,luminal,O
103928,7,irregularities,O
103928,7,.,O
103928,7,The,O
103928,7,LCX,O
103928,7,tapered,O
103928,7,quickly,O
103928,7,and,O
103928,7,was,O
103928,7,totally,O
103928,7,occluded,O
103928,7,in,O
103928,7,the,O
103928,7,proximal,O
103928,7,vessel,O
103928,7,after,O
103928,7,a,O
103928,7,small,O
103928,7,OM,O
103928,7,branch,O
103928,7,.,O
103928,7,The,O
103928,7,RCA,O
103928,7,was,O
103928,7,diffusely,O
103928,7,diseased,O
103928,7,and,O
103928,7,totally,O
103928,7,occluded,O
103928,7,proximally,O
103928,7,.,O
103928,7,2,O
103928,7,.,O
103928,7,Selective,O
103928,7,vein,O
103928,7,graft,O
103928,7,angiography,O
103928,7,revealed,O
103928,7,a,O
103928,7,widely,O
103928,7,patent,O
103928,7,SVG-,O
103928,7,>,O
103928,7,dRCA,O
103928,7,and,O
103928,7,a,O
103928,7,widely,O
103928,7,patent,O
103928,7,SVG-,O
103928,7,>,O
103928,7,D1/OM,O
103928,7,.,O
103928,7,3,O
103928,7,.,O
103928,7,Selective,O
103928,7,arterial,O
103928,7,conduit,O
103928,7,arteriography,O
103928,7,demonstrated,O
103928,7,a,O
103928,7,widely,O
103928,7,patent,O
103928,7,LIMA-,O
103928,7,>,O
103928,7,LAD,O
103928,7,.,O
103928,7,4,O
103928,7,.,O
103928,7,Resting,O
103928,7,hemodynamics,O
103928,7,revealed,O
103928,7,markedly,O
103928,7,elevated,O
103928,7,right,O
103928,7,and,O
103928,7,left,O
103928,7,ventricular,O
103928,7,filling,O
103928,8,pressures,O
103928,8,with,O
103928,8,an,O
103928,8,LVEDP,O
103928,8,of,O
103928,8,29,O
103928,8,mmHg,O
103928,8,and,O
103928,8,a,O
103928,8,mean,O
103928,8,PCW,O
103928,8,pressure,O
103928,8,of,O
103928,8,22,O
103928,8,mmHg,O
103928,8,.,O
103928,8,In,O
103928,8,addition,O
103928,8,",",O
103928,8,there,O
103928,8,were,O
103928,8,V-waves,O
103928,8,to,O
103928,8,50,O
103928,8,mmHg,O
103928,8,suggesting,O
103928,8,significant,O
103928,8,mitral,O
103928,8,regurgitation,O
103928,8,.,O
103928,8,There,O
103928,8,was,O
103928,8,evidence,O
103928,8,of,O
103928,8,moderate,O
103928,8,to,O
103928,8,severe,O
103928,8,pulmonary,O
103928,8,hypertension,O
103928,8,with,O
103928,8,PA,O
103928,8,pressures,O
103928,8,of,O
103928,8,62/21/39,O
103928,8,mmHg,O
103928,8,and,O
103928,8,a,O
103928,8,pulmonary,O
103928,8,vascular,O
103928,8,resistance,O
103928,8,of,O
103928,8,209,O
103928,8,dynes-sec/cm5,O
103928,8,.,O
103928,8,The,O
103928,8,cardiac,O
103928,8,output,O
103928,8,was,O
103928,8,preserved,O
103928,8,at,O
103928,8,6.9,O
103928,8,L/min,O
103928,8,.,O
103928,8,Note,O
103928,8,was,O
103928,8,made,O
103928,8,of,O
103928,8,a,O
103928,8,10,O
103928,8,mmHg,O
103928,8,gradient,O
103928,8,across,O
103928,8,the,O
103928,8,aortic,O
103928,8,valve,O
103928,8,.,O
103928,8,5,O
103928,8,.,O
103928,8,Left,O
103928,8,ventriculography,O
103928,8,was,O
103928,8,not,O
103928,8,performed,O
103928,8,due,O
103928,8,to,O
103928,8,the,O
103928,8,patient's,O
103928,8,underlying,O
103928,8,renal,O
103928,8,insufficiency,O
103928,8,and,O
103928,8,recent,O
103928,8,non-invasive,O
103928,8,testing,O
103928,8,documenting,O
103928,8,a,O
103928,8,preserved,O
103928,8,LV,O
103928,8,systolic,O
103928,8,function,O
103928,8,.,O
103928,8,.,O
103928,8,FINAL,O
103928,8,DIAGNOSIS,O
103928,8,:,O
103928,8,1,O
103928,8,.,O
103928,8,Severe,O
103928,8,native,O
103928,8,three,O
103928,8,vessel,O
103928,8,disease,O
103928,8,.,O
103928,8,2,O
103928,8,.,O
103928,8,Patent,O
103928,8,LIMA-,O
103928,8,>,O
103928,8,LAD,O
103928,8,.,O
103928,8,3,O
103928,8,.,O
103928,8,Patent,O
103928,8,SVG-,O
103928,8,>,O
103928,8,dRCA,O
103928,8,and,O
103928,8,SVG-,O
103928,8,>,O
103928,8,D1/OM,O
103928,8,.,O
103928,8,4,O
103928,8,.,O
103928,8,Moderate,O
103928,8,to,O
103928,8,severe,O
103928,8,left,O
103928,8,ventricular,O
103928,8,diastolic,O
103928,8,dysfunction,O
103928,8,.,O
103928,8,5,O
103928,8,.,O
103928,8,Moderate,O
103928,8,to,O
103928,8,severe,O
103928,8,pulmonary,O
103928,8,hypertension,O
103928,8,.,O
103928,8,CT,O
103928,8,head,O
103928,8,(,O
103928,8,[,O
103928,8,**9-24**,O
103928,8,],O
103928,8,),O
103928,8,:,O
103928,8,IMPRESSION,O
103928,8,:,O
103928,8,1,O
103928,8,.,O
103928,8,No,O
103928,8,acute,O
103928,8,intracranial,O
103928,8,process,O
103928,8,.,O
103928,8,2,O
103928,8,.,O
103928,8,Sequelae,O
103928,8,of,O
103928,8,chronic,O
103928,8,infarction,O
103928,8,involving,O
103928,8,the,O
103928,8,left,O
103928,8,parieto-occipital,O
103928,8,region,O
103928,8,.,O
103928,8,Renal,O
103928,8,U/S,O
103928,8,(,O
103928,8,[,O
103928,8,**9-27**,O
103928,8,],O
103928,8,),O
103928,8,:,O
103928,8,IMPRESSION,O
103928,8,:,O
103928,8,Absent,O
103928,8,diastolic,O
103928,8,flow,O
103928,8,seen,O
103928,8,in,O
103928,8,the,O
103928,8,bilateral,O
103928,8,interlobar,O
103928,8,arteries,O
103928,8,of,O
103928,8,the,O
103928,8,kidneys,O
103928,8,.,O
103928,8,The,O
103928,8,findings,O
103928,8,are,O
103928,8,nonspecific,O
103928,8,",",O
103928,8,but,O
103928,8,indicate,O
103928,8,renal,O
103928,8,parenchymal,O
103928,8,disease,O
103928,8,.,O
103928,8,There,O
103928,8,is,O
103928,8,limited,O
103928,8,evaluation,O
103928,8,of,O
103928,8,the,O
103928,8,main,O
103928,8,renal,O
103928,8,arteries,O
103928,8,",",O
103928,8,but,O
103928,8,there,O
103928,8,is,O
103928,8,no,O
103928,8,clear,O
103928,8,evidence,O
103928,8,of,O
103928,8,renal,O
103928,8,artery,O
103928,8,stenosis,O
103928,8,.,O
103928,8,There,O
103928,8,is,O
103928,8,no,O
103928,8,hydronephrosis,O
103928,8,.,O
103928,8,Brief,O
103928,8,Hospital,O
103928,8,Course,O
103928,8,:,O
103928,8,Summary,O
103928,8,:,O
103928,8,74,O
103928,8,yo,O
103928,8,M,O
103928,8,transferred,O
103928,8,from,O
103928,8,NWH,O
103928,8,with,O
103928,8,EKG,O
103928,8,changes,O
103928,8,",",O
103928,8,trop,O
103928,8,here,O
103928,8,to,O
103928,8,0.87,O
103928,8,(,O
103928,8,baseline,O
103928,8,0.2,O
103928,8,),O
103928,8,and,O
103928,8,RLE,O
103928,8,cellulitis,O
103928,8,",",O
103928,8,right,O
103928,8,foot,O
103928,8,osteomyelitis,O
103928,8,",",O
103928,8,worsening,O
103928,8,acute,O
103928,8,on,O
103928,8,chronic,O
103928,8,renal,O
103928,8,failure,O
103928,8,#,O
103928,8,Right,O
103928,8,lower,O
103928,8,extremity,O
103928,8,cellulitis,O
103928,8,and,O
103928,8,right,O
103928,8,foot,O
103928,8,osteomyelitis,O
103928,8,:,O
103928,8,The,O
103928,8,patient,O
103928,8,presented,O
103928,8,with,O
103928,8,right,O
103928,8,lower,O
103928,8,extremity,O
103928,8,cellulitis,O
103928,8,and,O
103928,8,was,O
103928,8,found,O
103928,8,to,O
103928,8,have,O
103928,8,osteomyelitis,O
103928,9,in,O
103928,9,the,O
103928,9,right,O
103928,9,foot,O
103928,9,.,O
103928,9,Vascular,O
103928,9,surgery,O
103928,9,evaluated,O
103928,9,the,O
103928,9,patient,O
103928,9,and,O
103928,9,thought,O
103928,9,that,O
103928,9,treatment,O
103928,9,for,O
103928,9,the,O
103928,9,infection,B-Reason
103928,9,and,O
103928,9,ischemia,O
103928,9,would,O
103928,9,be,O
103928,9,a,O
103928,9,below,O
103928,9,the,O
103928,9,knee,O
103928,9,amputation,O
103928,9,",",O
103928,9,though,O
103928,9,given,O
103928,9,the,O
103928,9,patient,O
103928,9,'s,O
103928,9,poor,O
103928,9,cardiac,O
103928,9,status,O
103928,9,",",O
103928,9,he,O
103928,9,would,O
103928,9,not,O
103928,9,be,O
103928,9,a,O
103928,9,good,O
103928,9,candidate,O
103928,9,for,O
103928,9,surgery,O
103928,9,.,O
103928,9,The,O
103928,9,patient,O
103928,9,was,O
103928,9,empirically,O
103928,9,started,O
103928,9,on,O
103928,9,Vancomycin,B-Drug
103928,9,and,O
103928,9,Zosyn,B-Drug
103928,9,.,O
103928,9,A,O
103928,9,wound,O
103928,9,culture,O
103928,9,grew,O
103928,9,Klebsiella,O
103928,9,oxytoca,O
103928,9,and,O
103928,9,MRSA,O
103928,9,and,O
103928,9,continued,O
103928,9,on,O
103928,9,those,O
103928,9,antibiotics,O
103928,9,.,O
103928,9,Since,O
103928,9,vascular,O
103928,9,surgery,O
103928,9,would,O
103928,9,be,O
103928,9,high,O
103928,9,risk,O
103928,9,",",O
103928,9,podiatry,O
103928,9,was,O
103928,9,consulted,O
103928,9,for,O
103928,9,local,O
103928,9,debridement,O
103928,9,.,O
103928,9,They,O
103928,9,debrided,O
103928,9,the,O
103928,9,area,O
103928,9,locally,O
103928,9,",",O
103928,9,yet,O
103928,9,erythema,O
103928,9,of,O
103928,9,the,O
103928,9,right,O
103928,9,foot,O
103928,9,existed,O
103928,9,.,O
103928,9,It,O
103928,9,remained,O
103928,9,unclear,O
103928,9,whether,O
103928,9,the,O
103928,9,erythema,O
103928,9,was,O
103928,9,due,O
103928,9,to,O
103928,9,ischemia,O
103928,9,vs.,O
103928,9,a,O
103928,9,subcutaneous,O
103928,9,abscess,O
103928,9,",",O
103928,9,so,O
103928,9,they,O
103928,9,recommended,O
103928,9,a,O
103928,9,MRI,O
103928,9,of,O
103928,9,the,O
103928,9,foot,O
103928,9,.,O
103928,9,The,O
103928,9,MRI,O
103928,9,was,O
103928,9,never,O
103928,9,performed,O
103928,9,because,O
103928,9,after,O
103928,9,discussion,O
103928,9,with,O
103928,9,the,O
103928,9,family,O
103928,9,and,O
103928,9,primary,O
103928,9,care,O
103928,9,physician,O
103928,9,",",O
103928,9,[,O
103928,9,**Name10,O
103928,9,(,O
103928,9,NameIs,O
103928,9,),O
103928,9,**,O
103928,9,],O
103928,9,was,O
103928,9,decided,O
103928,9,for,O
103928,9,the,O
103928,9,patient,O
103928,9,to,O
103928,9,become,O
103928,9,CMO,O
103928,9,.,O
103928,9,His,O
103928,9,antibiotics,O
103928,9,were,O
103928,9,withdrawn,O
103928,9,and,O
103928,9,wound,O
103928,9,care,O
103928,9,applied,O
103928,9,to,O
103928,9,the,O
103928,9,area,O
103928,9,.,O
103928,9,#,O
103928,9,Acute,O
103928,9,on,O
103928,9,chronic,O
103928,9,renal,O
103928,9,failure,O
103928,9,:,O
103928,9,The,O
103928,9,patient,O
103928,9,presented,O
103928,9,with,O
103928,9,a,O
103928,9,creatinine,O
103928,9,close,O
103928,9,to,O
103928,9,his,O
103928,9,baseline,O
103928,9,",",O
103928,9,however,O
103928,9,",",O
103928,9,after,O
103928,9,periods,O
103928,9,of,O
103928,9,hypotension,O
103928,9,",",O
103928,9,likely,O
103928,9,due,O
103928,9,to,O
103928,9,a,O
103928,9,peri-septic,O
103928,9,state,O
103928,9,",",O
103928,9,his,O
103928,9,creatinine,O
103928,9,starting,O
103928,9,to,O
103928,9,rise,O
103928,9,.,O
103928,9,He,O
103928,9,was,O
103928,9,given,O
103928,9,fluid,O
103928,9,boluses,O
103928,9,of,O
103928,9,500,O
103928,9,cc,O
103928,9,of,O
103928,9,normal,B-Drug
103928,9,saline,I-Drug
103928,9,as,O
103928,9,needed,O
103928,9,because,O
103928,9,his,O
103928,9,urine,O
103928,9,lytes,O
103928,9,showed,O
103928,9,a,O
103928,9,FeUrea~20-25,O
103928,9,%,O
103928,9,.,O
103928,9,Renal,O
103928,9,was,O
103928,9,consulted,O
103928,9,and,O
103928,9,thought,O
103928,9,his,O
103928,9,creatinine,O
103928,9,rise,O
103928,9,was,O
103928,9,likely,O
103928,9,due,O
103928,9,to,O
103928,9,acute,O
103928,9,tubular,O
103928,9,necrosis,O
103928,9,secondary,O
103928,9,to,O
103928,9,a,O
103928,9,pre-renal,O
103928,9,state,O
103928,9,.,O
103928,9,The,O
103928,9,patient,O
103928,9,was,O
103928,9,offered,O
103928,9,aluminium,O
103928,9,hydroxide,O
103928,9,for,O
103928,9,high,O
103928,9,phosphate,O
103928,9,levels,O
103928,9,",",O
103928,9,but,O
103928,9,the,O
103928,9,patient,O
103928,9,refused,O
103928,9,it,O
103928,9,.,O
103928,9,A,O
103928,9,renal,O
103928,9,ultrasound,O
103928,9,showed,O
103928,9,no,O
103928,9,hydronephrosis,O
103928,9,.,O
103928,9,The,O
103928,9,patient,O
103928,9,became,O
103928,9,progressively,O
103928,9,oliguric,O
103928,9,with,O
103928,9,UOP,O
103928,9,less,O
103928,9,than,O
103928,9,20,O
103928,9,cc/hour,O
103928,9,.,O
103928,9,Renal,O
103928,9,thought,O
103928,9,his,O
103928,9,kidneys,O
103928,9,would,O
103928,9,unlikely,O
103928,9,recover,O
103928,9,(,O
103928,9,his,O
103928,9,creatinine,O
103928,9,rose,O
103928,9,to,O
103928,9,5.3,O
103928,9,despite,O
103928,9,interventions,O
103928,9,),O
103928,10,.,O
103928,10,The,O
103928,10,patient,O
103928,10,and,O
103928,10,his,O
103928,10,family,O
103928,10,felt,O
103928,10,that,O
103928,10,they,O
103928,10,did,O
103928,10,not,O
103928,10,want,O
103928,10,to,O
103928,10,pursue,O
103928,10,dialysis,O
103928,10,as,O
103928,10,an,O
103928,10,option,O
103928,10,.,O
103928,10,#,O
103928,10,Increased,O
103928,10,troponins,O
103928,10,:,O
103928,10,The,O
103928,10,patient,O
103928,10,was,O
103928,10,noted,O
103928,10,to,O
103928,10,have,O
103928,10,high,O
103928,10,troponins,O
103928,10,and,O
103928,10,excentuated,O
103928,10,ST,O
103928,10,wave,O
103928,10,depressions,O
103928,10,in,O
103928,10,V3-V5,O
103928,10,.,O
103928,10,Cardiology,O
103928,10,was,O
103928,10,consulted,O
103928,10,and,O
103928,10,recommended,O
103928,10,medical,O
103928,10,management,O
103928,10,with,O
103928,10,a,O
103928,10,beta,B-Drug
103928,10,blocker,I-Drug
103928,10,",",O
103928,10,ACE,B-Drug
103928,10,inhibitor,I-Drug
103928,10,",",O
103928,10,statin,O
103928,10,",",O
103928,10,and,O
103928,10,aspirin,B-Drug
103928,10,.,O
103928,10,The,O
103928,10,patient,O
103928,10,was,O
103928,10,started,O
103928,10,on,O
103928,10,these,O
103928,10,medications,O
103928,10,",",O
103928,10,though,O
103928,10,became,O
103928,10,persistently,O
103928,10,hyperkalemic,O
103928,10,",",O
103928,10,and,O
103928,10,therefore,O
103928,10,",",O
103928,10,the,O
103928,10,ACEi,O
103928,10,was,O
103928,10,discontinued,O
103928,10,.,O
103928,10,Also,O
103928,10,",",O
103928,10,his,O
103928,10,CK,O
103928,10,and,O
103928,10,LFTs,O
103928,10,were,O
103928,10,[,O
103928,10,**Last,O
103928,10,Name,O
103928,10,(,O
103928,10,LF,O
103928,10,),O
103928,10,28645**,O
103928,10,],O
103928,10,",",O
103928,10,[,O
103928,10,**First,O
103928,10,Name3,O
103928,10,(,O
103928,10,LF,O
103928,10,),O
103928,10,**,O
103928,10,],O
103928,10,the,O
103928,10,statin,O
103928,10,dose,O
103928,10,of,O
103928,10,80,O
103928,10,mg,O
103928,10,was,O
103928,10,lowered,O
103928,10,to,O
103928,10,20,O
103928,10,mg,O
103928,10,and,O
103928,10,eventually,O
103928,10,discontinued,O
103928,10,due,O
103928,10,to,O
103928,10,persistently,O
103928,10,[,O
103928,10,**First,O
103928,10,Name3,O
103928,10,(,O
103928,10,LF,O
103928,10,),O
103928,10,28645**,O
103928,10,],O
103928,10,LFTs,O
103928,10,.,O
103928,10,An,O
103928,10,echocardiogram,O
103928,10,revealed,O
103928,10,no,O
103928,10,acute,O
103928,10,wall,O
103928,10,motion,O
103928,10,abnormality,O
103928,10,",",O
103928,10,though,O
103928,10,it,O
103928,10,did,O
103928,10,show,O
103928,10,worsening,O
103928,10,tricuspid,O
103928,10,regurgitation,O
103928,10,and,O
103928,10,increased,O
103928,10,pulmonary,O
103928,10,artery,O
103928,10,pressure,O
103928,10,.,O
103928,10,Throughout,O
103928,10,his,O
103928,10,stay,O
103928,10,",",O
103928,10,the,O
103928,10,patient,O
103928,10,did,O
103928,10,not,O
103928,10,have,O
103928,10,any,O
103928,10,chest,O
103928,10,pain,O
103928,10,.,O
103928,10,#,O
103928,10,Increased,O
103928,10,LFTs,O
103928,10,:,O
103928,10,The,O
103928,10,patient,O
103928,10,has,O
103928,10,a,O
103928,10,known,O
103928,10,history,O
103928,10,of,O
103928,10,alcohol,O
103928,10,abuse,O
103928,10,and,O
103928,10,increased,O
103928,10,LFTs,O
103928,10,in,O
103928,10,the,O
103928,10,past,O
103928,10,.,O
103928,10,During,O
103928,10,his,O
103928,10,peri-septic,O
103928,10,period,O
103928,10,",",O
103928,10,the,O
103928,10,patient,O
103928,10,was,O
103928,10,noted,O
103928,10,to,O
103928,10,have,O
103928,10,increased,O
103928,10,LFTs,O
103928,10,",",O
103928,10,likely,O
103928,10,multifactorial,O
103928,10,due,O
103928,10,to,O
103928,10,low,O
103928,10,perfusion,O
103928,10,to,O
103928,10,the,O
103928,10,liver,O
103928,10,and,O
103928,10,also,O
103928,10,congestion,O
103928,10,secondary,O
103928,10,to,O
103928,10,tricuspid,O
103928,10,regurgitation,O
103928,10,.,O
103928,10,The,O
103928,10,patient,O
103928,10,did,O
103928,10,not,O
103928,10,have,O
103928,10,any,O
103928,10,complaints,O
103928,10,of,O
103928,10,abdominal,O
103928,10,pain,O
103928,10,",",O
103928,10,though,O
103928,10,",",O
103928,10,he,O
103928,10,had,O
103928,10,hepatomegaly,O
103928,10,on,O
103928,10,exam,O
103928,10,.,O
103928,10,#,O
103928,10,Gastrointestinal,B-ADE
103928,10,bleed,I-ADE
103928,10,:,O
103928,10,The,O
103928,10,patient,O
103928,10,has,O
103928,10,a,O
103928,10,history,O
103928,10,of,O
103928,10,a,O
103928,10,GI,O
103928,10,bleed,O
103928,10,and,O
103928,10,was,O
103928,10,guiaic,O
103928,10,positive,O
103928,10,in,O
103928,10,the,O
103928,10,ER,O
103928,10,.,O
103928,10,In,O
103928,10,addition,O
103928,10,",",O
103928,10,he,O
103928,10,had,O
103928,10,a,O
103928,10,persistently,O
103928,10,elevated,O
103928,10,PT/PTT,O
103928,10,",",O
103928,10,likely,O
103928,10,due,O
103928,10,to,O
103928,10,either,O
103928,10,underlying,O
103928,10,liver,O
103928,10,or,O
103928,10,hematologic,O
103928,10,disease,O
103928,10,.,O
103928,10,The,O
103928,10,patient,O
103928,10,'s,O
103928,10,hematocrit,O
103928,10,remained,O
103928,10,stable,O
103928,10,until,O
103928,10,[,O
103928,10,**9-26**,O
103928,10,],O
103928,10,when,O
103928,10,his,O
103928,10,hematocrit,O
103928,10,dropped,O
103928,10,from,O
103928,10,29.0,O
103928,10,to,O
103928,10,25.6,O
103928,10,and,O
103928,10,was,O
103928,10,noted,O
103928,10,to,O
103928,10,have,O
103928,11,melenic,O
103928,11,stools,O
103928,11,.,O
103928,11,He,O
103928,11,continued,O
103928,11,to,O
103928,11,have,O
103928,11,melenic,O
103928,11,stools,O
103928,11,",",O
103928,11,so,O
103928,11,he,O
103928,11,was,O
103928,11,transfused,O
103928,11,one,O
103928,11,unit,O
103928,11,of,O
103928,11,blood,O
103928,11,and,O
103928,11,transferred,O
103928,11,to,O
103928,11,the,O
103928,11,MICU,O
103928,11,.,O
103928,11,His,O
103928,11,aspirin,B-Drug
103928,11,was,O
103928,11,discontinued,O
103928,11,.,O
103928,11,His,O
103928,11,hematocrit,O
103928,11,remained,O
103928,11,stable,O
103928,11,in,O
103928,11,the,O
103928,11,MICU,O
103928,11,and,O
103928,11,transferred,O
103928,11,to,O
103928,11,the,O
103928,11,floors,O
103928,11,where,O
103928,11,there,O
103928,11,were,O
103928,11,no,O
103928,11,signs,O
103928,11,of,O
103928,11,any,O
103928,11,GI,O
103928,11,bleeding,O
103928,11,.,O
103928,11,Altered,O
103928,11,mental,O
103928,11,status,O
103928,11,:,O
103928,11,The,O
103928,11,patient,O
103928,11,had,O
103928,11,periods,O
103928,11,where,O
103928,11,he,O
103928,11,had,O
103928,11,altered,O
103928,11,mental,O
103928,11,status,O
103928,11,",",O
103928,11,mostly,O
103928,11,at,O
103928,11,night,O
103928,11,.,O
103928,11,His,O
103928,11,AMS,O
103928,11,was,O
103928,11,likely,O
103928,11,multifactorial,O
103928,11,due,O
103928,11,to,O
103928,11,infection,O
103928,11,",",O
103928,11,pain,O
103928,11,and,O
103928,11,uremia,O
103928,11,.,O
103928,11,He,O
103928,11,had,O
103928,11,significant,O
103928,11,altered,O
103928,11,mental,O
103928,11,status,O
103928,11,on,O
103928,11,one,O
103928,11,day,O
103928,11,when,O
103928,11,he,O
103928,11,appeared,O
103928,11,more,O
103928,11,somnolent,O
103928,11,with,O
103928,11,respirations=10/min,O
103928,11,after,O
103928,11,a,O
103928,11,dose,O
103928,11,of,O
103928,11,Morphine,B-Drug
103928,11,2mg,O
103928,11,IV,O
103928,11,.,O
103928,11,Narcane,O
103928,11,was,O
103928,11,given,O
103928,11,with,O
103928,11,some,O
103928,11,effect,O
103928,11,.,O
103928,11,A,O
103928,11,head,O
103928,11,CT,O
103928,11,showed,O
103928,11,no,O
103928,11,acute,O
103928,11,pathology,O
103928,11,.,O
103928,11,He,O
103928,11,continued,O
103928,11,to,O
103928,11,have,O
103928,11,periods,O
103928,11,of,O
103928,11,delirium,O
103928,11,mostly,O
103928,11,at,O
103928,11,night,O
103928,11,.,O
103928,11,#,O
103928,11,Pruritis,B-ADE
103928,11,:,O
103928,11,The,O
103928,11,patient,O
103928,11,has,O
103928,11,been,O
103928,11,complaining,O
103928,11,of,O
103928,11,pruritis,O
103928,11,",",O
103928,11,especially,O
103928,11,on,O
103928,11,his,O
103928,11,back,O
103928,11,",",O
103928,11,since,O
103928,11,admission,O
103928,11,.,O
103928,11,A,O
103928,11,variety,O
103928,11,of,O
103928,11,remedies,O
103928,11,were,O
103928,11,tried,O
103928,11,for,O
103928,11,wound,O
103928,11,care,O
103928,11,.,O
103928,11,According,O
103928,11,to,O
103928,11,his,O
103928,11,son,O
103928,11,",",O
103928,11,the,O
103928,11,pruritis,O
103928,11,has,O
103928,11,been,O
103928,11,long-standing,O
103928,11,.,O
103928,11,It,O
103928,11,might,O
103928,11,be,O
103928,11,exacerbated,O
103928,11,by,O
103928,11,his,O
103928,11,renal,O
103928,11,failure,O
103928,11,.,O
103928,11,A,O
103928,11,side,O
103928,11,effect,O
103928,11,of,O
103928,11,Morphine,B-Drug
103928,11,is,O
103928,11,a,O
103928,11,possibility,O
103928,11,",",O
103928,11,but,O
103928,11,he,O
103928,11,still,O
103928,11,had,O
103928,11,the,O
103928,11,itching,B-Reason
103928,11,even,O
103928,11,before,O
103928,11,the,O
103928,11,morphine,B-Drug
103928,11,.,O
103928,11,He,O
103928,11,is,O
103928,11,being,O
103928,11,treated,O
103928,11,with,O
103928,11,skin,O
103928,11,care,O
103928,11,",",O
103928,11,sarna,B-Drug
103928,11,lotion,O
103928,11,",",O
103928,11,hydrocortisone,B-Drug
103928,11,and,O
103928,11,doxepin,B-Drug
103928,11,.,O
103928,11,Goals,O
103928,11,of,O
103928,11,care,O
103928,11,:,O
103928,11,The,O
103928,11,patient,O
103928,11,entered,O
103928,11,the,O
103928,11,hospital,O
103928,11,as,O
103928,11,full,O
103928,11,code,O
103928,11,.,O
103928,11,After,O
103928,11,the,O
103928,11,renal,O
103928,11,and,O
103928,11,GI,O
103928,11,bleeding,O
103928,11,complications,O
103928,11,from,O
103928,11,his,O
103928,11,illness,O
103928,11,",",O
103928,11,the,O
103928,11,patient,O
103928,11,and,O
103928,11,his,O
103928,11,family,O
103928,11,decided,O
103928,11,to,O
103928,11,become,O
103928,11,DNR/DNI,O
103928,11,.,O
103928,11,After,O
103928,11,a,O
103928,11,meeting,O
103928,11,with,O
103928,11,the,O
103928,11,PCP,O
103928,11,and,O
103928,11,the,O
103928,11,family,O
103928,11,",",O
103928,11,they,O
103928,11,thought,O
103928,11,the,O
103928,11,best,O
103928,11,route,O
103928,11,would,O
103928,11,be,O
103928,11,to,O
103928,11,become,O
103928,11,comfort,O
103928,11,measures,O
103928,11,only,O
103928,11,instead,O
103928,11,of,O
103928,11,pursuing,O
103928,11,dialysis,O
103928,11,and,O
103928,11,being,O
103928,11,chronically,O
103928,11,cared,O
103928,11,for,O
103928,11,in,O
103928,11,a,O
103928,11,nursing,O
103928,11,home,O
103928,11,.,O
103928,11,At,O
103928,11,first,O
103928,11,",",O
103928,11,it,O
103928,11,was,O
103928,11,thought,O
103928,11,that,O
103928,11,his,O
103928,11,beta,B-Drug
103928,11,blocker,I-Drug
103928,11,",",O
103928,11,aspirin,B-Drug
103928,11,",",O
103928,12,and,O
103928,12,antibiotics,B-Drug
103928,12,would,O
103928,12,be,O
103928,12,continued,O
103928,12,",",O
103928,12,however,O
103928,12,",",O
103928,12,after,O
103928,12,further,O
103928,12,conversation,O
103928,12,",",O
103928,12,these,O
103928,12,medications,O
103928,12,were,O
103928,12,discontinued,O
103928,12,and,O
103928,12,only,O
103928,12,palliative,O
103928,12,measures,O
103928,12,for,O
103928,12,insomnia,O
103928,12,",",O
103928,12,anxiety,O
103928,12,",",O
103928,12,pain,O
103928,12,and,O
103928,12,constipation,O
103928,12,were,O
103928,12,ordered,O
103928,12,.,O
103928,12,Medications,O
103928,12,on,O
103928,12,Admission,O
103928,12,:,O
103928,12,MEDICATIONS,O
103928,12,(,O
103928,12,from,O
103928,12,NWH,O
103928,12,D/C,O
103928,12,summary,O
103928,12,on,O
103928,12,[,O
103928,12,**9-11**,O
103928,12,],O
103928,12,),O
103928,12,acetaminophen,B-Drug
103928,12,1,O
103928,12,g,O
103928,12,q8hr,O
103928,12,ASA,B-Drug
103928,12,325,O
103928,12,Daily,O
103928,12,Erythropoietin,B-Drug
103928,12,4000,O
103928,12,units,O
103928,12,SC,O
103928,12,weekly,O
103928,12,Ferrous,B-Drug
103928,12,sulfate,I-Drug
103928,12,325,O
103928,12,mg,O
103928,12,Daily,O
103928,12,Furosemide,B-Drug
103928,12,40,O
103928,12,mg,O
103928,12,daily,O
103928,12,Lovenox,B-Drug
103928,12,30,O
103928,12,mg,O
103928,12,SC,O
103928,12,daily,O
103928,12,until,O
103928,12,ambulatory,O
103928,12,NPH,B-Drug
103928,12,(,O
103928,12,8,O
103928,12,units,O
103928,12,before,O
103928,12,breakfast,O
103928,12,and,O
103928,12,dinner,O
103928,12,Regular,B-Drug
103928,12,insulin,I-Drug
103928,12,(,O
103928,12,5,O
103928,12,units,O
103928,12,before,O
103928,12,breakfast,O
103928,12,and,O
103928,12,dinner,O
103928,12,Metoprolol,B-Drug
103928,12,12.5,O
103928,12,mg,O
103928,12,[,O
103928,12,**Hospital1,O
103928,12,**,O
103928,12,],O
103928,12,MVT,O
103928,12,daily,O
103928,12,Miralax,B-Drug
103928,12,17,O
103928,12,g,O
103928,12,Daily,O
103928,12,Nystain,B-Drug
103928,12,triamcinolone,I-Drug
103928,12,cream,O
103928,12,topically,O
103928,12,twice,O
103928,12,daily,O
103928,12,omeprazole,B-Drug
103928,12,29,O
103928,12,mg,O
103928,12,daily,O
103928,12,Sarna,B-Drug
103928,12,lotion,O
103928,12,to,O
103928,12,affected,O
103928,12,area,O
103928,12,[,O
103928,12,**Hospital1,O
103928,12,**,O
103928,12,],O
103928,12,senokot,B-Drug
103928,12,qHs,O
103928,12,Sertraline,B-Drug
103928,12,50,O
103928,12,mg,O
103928,12,daily,O
103928,12,simvastatin,B-Drug
103928,12,20,O
103928,12,mg,O
103928,12,daily,O
103928,12,flomax,B-Drug
103928,12,0.4,O
103928,12,mg,O
103928,12,daily,O
103928,12,Discharge,O
103928,12,Medications,O
103928,12,:,O
103928,12,1,O
103928,12,.,O
103928,12,Sertraline,B-Drug
103928,12,50,O
103928,12,mg,O
103928,12,Tablet,O
103928,12,Sig,O
103928,12,:,O
103928,12,One,O
103928,12,(,O
103928,12,1,O
103928,12,),O
103928,12,Tablet,O
103928,12,PO,O
103928,12,DAILY,O
103928,12,(,O
103928,12,Daily,O
103928,12,),O
103928,12,.,O
103928,12,2,O
103928,12,.,O
103928,12,Camphor-Menthol,B-Drug
103928,12,0.5-0.5,O
103928,12,%,O
103928,12,Lotion,O
103928,12,Sig,O
103928,12,:,O
103928,12,One,O
103928,12,(,O
103928,12,1,O
103928,12,),O
103928,12,Appl,O
103928,12,Topical,O
103928,12,QID,O
103928,12,(,O
103928,12,4,O
103928,12,times,O
103928,12,a,O
103928,12,day,O
103928,12,),O
103928,12,as,O
103928,12,needed,O
103928,12,for,O
103928,12,itching,B-Reason
103928,12,.,O
103928,12,3,O
103928,12,.,O
103928,12,Acetaminophen,B-Drug
103928,12,325,O
103928,12,mg,O
103928,12,Tablet,O
103928,12,Sig,O
103928,12,:,O
103928,12,1-2,O
103928,12,Tablets,O
103928,12,PO,O
103928,12,Q6H,O
103928,12,(,O
103928,12,every,O
103928,12,6,O
103928,12,hours,O
103928,12,),O
103928,12,as,O
103928,12,needed,O
103928,12,for,O
103928,12,fever,B-Reason
103928,12,",",O
103928,12,pain,B-Reason
103928,12,.,O
103928,12,4,O
103928,12,.,O
103928,12,Quetiapine,B-Drug
103928,12,25,O
103928,12,mg,O
103928,12,Tablet,O
103928,12,Sig,O
103928,12,:,O
103928,12,One,O
103928,12,(,O
103928,12,1,O
103928,12,),O
103928,12,Tablet,O
103928,12,PO,O
103928,12,QHS,O
103928,12,(,O
103928,12,once,O
103928,12,a,O
103928,12,day,O
103928,12,(,O
103928,12,at,O
103928,12,bedtime,O
103928,12,),O
103928,12,),O
103928,12,.,O
103928,12,5,O
103928,12,.,O
103928,12,Trazodone,B-Drug
103928,12,50,O
103928,12,mg,O
103928,12,Tablet,O
103928,12,Sig,O
103928,12,:,O
103928,12,One,O
103928,12,(,O
103928,12,1,O
103928,12,),O
103928,12,Tablet,O
103928,12,PO,O
103928,12,HS,O
103928,12,(,O
103928,12,at,O
103928,12,bedtime,O
103928,12,),O
103928,12,as,O
103928,12,needed,O
103928,12,for,O
103928,12,insomnia,B-Reason
103928,12,.,O
103928,12,6,O
103928,12,.,O
103928,12,Senna,B-Drug
103928,12,8.6,O
103928,12,mg,O
103928,12,Tablet,O
103928,12,Sig,O
103928,12,:,O
103928,12,One,O
103928,12,(,O
103928,12,1,O
103928,12,),O
103928,12,Tablet,O
103928,12,PO,O
103928,12,BID,O
103928,12,(,O
103928,12,2,O
103928,12,times,O
103928,12,a,O
103928,12,day,O
103928,12,),O
103928,12,as,O
103928,12,needed,O
103928,12,for,O
103928,12,constipation,B-Reason
103928,12,.,O
103928,12,7,O
103928,12,.,O
103928,12,Docusate,B-Drug
103928,12,Sodium,I-Drug
103928,12,100,O
103928,12,mg,O
103928,12,Capsule,O
103928,12,Sig,O
103928,12,:,O
103928,12,One,O
103928,12,(,O
103928,12,1,O
103928,12,),O
103928,12,Capsule,O
103928,12,PO,O
103928,12,BID,O
103928,13,(,O
103928,13,2,O
103928,13,times,O
103928,13,a,O
103928,13,day,O
103928,13,),O
103928,13,as,O
103928,13,needed,O
103928,13,for,O
103928,13,constipation,B-Reason
103928,13,.,O
103928,13,8,O
103928,13,.,O
103928,13,Morphine,B-Drug
103928,13,10,O
103928,13,mg/5,O
103928,13,mL,O
103928,13,Solution,O
103928,13,Sig,O
103928,13,:,O
103928,13,[,O
103928,13,**4-29**,O
103928,13,],O
103928,13,mL,O
103928,13,PO,O
103928,13,Q4H,O
103928,13,(,O
103928,13,every,O
103928,13,4,O
103928,13,hours,O
103928,13,),O
103928,13,as,O
103928,13,needed,O
103928,13,for,O
103928,13,pain,B-Reason
103928,13,",",O
103928,13,respiratory,B-Reason
103928,13,distress,I-Reason
103928,13,.,O
103928,13,9,O
103928,13,.,O
103928,13,Hydrocortisone,B-Drug
103928,13,2.5,O
103928,13,%,O
103928,13,Cream,O
103928,13,Sig,O
103928,13,:,O
103928,13,One,O
103928,13,(,O
103928,13,1,O
103928,13,),O
103928,13,Appl,O
103928,13,Rectal,O
103928,13,TID,O
103928,13,(,O
103928,13,3,O
103928,13,times,O
103928,13,a,O
103928,13,day,O
103928,13,),O
103928,13,as,O
103928,13,needed,O
103928,13,for,O
103928,13,itching,B-Reason
103928,13,.,O
103928,13,10,O
103928,13,.,O
103928,13,Doxepin,B-Drug
103928,13,25,O
103928,13,mg,O
103928,13,Capsule,O
103928,13,Sig,O
103928,13,:,O
103928,13,One,O
103928,13,(,O
103928,13,1,O
103928,13,),O
103928,13,Capsule,O
103928,13,PO,O
103928,13,BID,O
103928,13,(,O
103928,13,2,O
103928,13,times,O
103928,13,a,O
103928,13,day,O
103928,13,),O
103928,13,.,O
103928,13,11,O
103928,13,.,O
103928,13,Quetiapine,B-Drug
103928,13,25,O
103928,13,mg,O
103928,13,Tablet,O
103928,13,Sig,O
103928,13,:,O
103928,13,One,O
103928,13,(,O
103928,13,1,O
103928,13,),O
103928,13,Tablet,O
103928,13,PO,O
103928,13,Q6H,O
103928,13,(,O
103928,13,every,O
103928,13,6,O
103928,13,hours,O
103928,13,),O
103928,13,as,O
103928,13,needed,O
103928,13,for,O
103928,13,anxiety,B-Reason
103928,13,.,O
103928,13,12,O
103928,13,.,O
103928,13,Zofran,B-Drug
103928,13,2,O
103928,13,mg/mL,O
103928,13,Solution,O
103928,13,Sig,O
103928,13,:,O
103928,13,Four,O
103928,13,(,O
103928,13,4,O
103928,13,),O
103928,13,mg,O
103928,13,Intravenous,O
103928,13,every,O
103928,13,six,O
103928,13,(,O
103928,13,6,O
103928,13,),O
103928,13,hours,O
103928,13,as,O
103928,13,needed,O
103928,13,for,O
103928,13,nausea,B-Reason
103928,13,.,O
103928,13,Discharge,O
103928,13,Disposition,O
103928,13,:,O
103928,13,Extended,O
103928,13,Care,O
103928,13,Facility,O
103928,13,:,O
103928,13,Cape,O
103928,13,Code,O
103928,13,Nursing,O
103928,13,&,O
103928,13,Rehabilitation,O
103928,13,Center,O
103928,13,-,O
103928,13,[,O
103928,13,**Location,O
103928,13,(,O
103928,13,un,O
103928,13,),O
103928,13,10072**,O
103928,13,],O
103928,13,Discharge,O
103928,13,Diagnosis,O
103928,13,:,O
103928,13,Primary,O
103928,13,-cellulitis,O
103928,13,of,O
103928,13,lower,O
103928,13,extremity,O
103928,13,-osteomyelitis,O
103928,13,-coronary,O
103928,13,artery,O
103928,13,disease,O
103928,13,.,O
103928,13,Secondary,O
103928,13,-Hypotension,O
103928,13,-Type,O
103928,13,II,O
103928,13,diabetes,O
103928,13,Mellitus,O
103928,13,Discharge,O
103928,13,Condition,O
103928,13,:,O
103928,13,Stable,O
103928,13,.,O
103928,13,Patient,O
103928,13,breathing,O
103928,13,on,O
103928,13,room,O
103928,13,air,O
103928,13,.,O
103928,13,Discharge,O
103928,13,Instructions,O
103928,13,:,O
103928,13,You,O
103928,13,were,O
103928,13,transferred,O
103928,13,to,O
103928,13,the,O
103928,13,hospital,O
103928,13,with,O
103928,13,right,O
103928,13,foot,O
103928,13,cellulitis,O
103928,13,and,O
103928,13,osteomyelitis,O
103928,13,.,O
103928,13,You,O
103928,13,were,O
103928,13,started,O
103928,13,on,O
103928,13,antibiotics,O
103928,13,.,O
103928,13,Vascular,O
103928,13,surgery,O
103928,13,evaluated,O
103928,13,the,O
103928,13,foot,O
103928,13,and,O
103928,13,were,O
103928,13,cautious,O
103928,13,to,O
103928,13,pursue,O
103928,13,surgical,O
103928,13,intervention,O
103928,13,because,O
103928,13,you,O
103928,13,have,O
103928,13,a,O
103928,13,poor,O
103928,13,cardiac,O
103928,13,reserve,O
103928,13,.,O
103928,13,Podiatry,O
103928,13,evaluated,O
103928,13,you,O
103928,13,and,O
103928,13,they,O
103928,13,...,O
103928,13,.,O
103928,13,.,O
103928,13,You,O
103928,13,should,O
103928,13,come,O
103928,13,back,O
103928,13,to,O
103928,13,the,O
103928,13,hospital,O
103928,13,or,O
103928,13,call,O
103928,13,your,O
103928,13,primary,O
103928,13,care,O
103928,13,doctor,O
103928,13,if,O
103928,13,you,O
103928,13,have,O
103928,13,chest,O
103928,13,pain,O
103928,13,",",O
103928,13,shortness,O
103928,13,of,O
103928,13,breath,O
103928,13,",",O
103928,13,weight,O
103928,13,gain,O
103928,13,",",O
103928,13,fevers/chills,O
103928,13,or,O
103928,13,increasing,O
103928,13,pain,O
103928,13,in,O
103928,13,your,O
103928,13,right,O
103928,13,foot,O
103928,13,.,O
103928,13,Followup,O
103928,13,Instructions,O
103928,13,:,O
103928,13,PRN,O
